12:00 AM
May 21, 2012
 |  BC Week In Review  |  Company News  |  Deals

Neurotune, ALS Therapy Development Institute (ALS TDI) deal

ALS TDI said it will evaluate the efficacy of Neurotune's TDI-165 in a...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >